S
Signos
Weight Loss Plan | Device | App | CGM | Signos
About Signos
Signos is a health-tech startup that operates in the wellness and weight-loss market. The company offers a wearable device and an accompanying app that help users manage their metabolism and achieve their health goals. The wearable device tracks real-time blood sugar levels and trends, and the app provides personalized recommendations based on the user's unique metabolic response to food.
Signos targets individuals who are looking to lose weight, manage their blood sugar levels, or generally improve their health. The company's business model is subscription-based, where users sign up and subscribe to receive the wearable device and access to the app's features.
The app offers a range of features, including in-app nutritionist support, predictive glucose for meals, fasting and meal timing tips, exercise and activity recommendations, and alerts for glucose spikes. The app's AI technology uses millions of data points to provide these personalized recommendations, helping users make informed decisions about their diet and lifestyle.
Signos generates revenue through its subscription fees. The company also appears to have venture capital backing, suggesting potential for growth and expansion in the future.
In summary, Signos is a health-tech startup offering a wearable device and app that provide personalized recommendations for managing metabolism and improving health. The company operates in the wellness and weight-loss market, serving individuals looking to improve their health and lifestyle.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Palo Alto, United States
- Employees
- 102
- Open positions
- None listed
- Dealroom signal
- 68.7/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Weight Management, Nutrition, Metabolism, Hard Tech
- Technology
- Artificial Intelligence
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Oct 2023 | $20M | $80M | GV · Cheyenne Ventures · Dexcom Ventures · Samsung Next | ↗ |
| SERIES A✓Equity / VC | Nov 2021 | $13M | $52M | GV | ↗ |
Growth signals
Latest recorded traffic for Signos is 140K monthly website visits, up 70.7% over the last three months. Signos's team declined 12.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
GV- CVCheyenne Ventures
- DVDexcom Ventures
Samsung Next
Other known investors6 additional known investors
1984 Ventures
Fifth Down Capital- RRRebecca Rudisch
Small Business Innovation Research
StartFast Ventures
Tau Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Signos on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Signos’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







